Ozempic and Cefdinir drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Ozempic (semaglutide) and Cefdinir (cefdinir). Common drug interactions include productive cough among females and death among males.

The phase IV clinical study analyzes what interactions people have when they take Ozempic and Cefdinir. It is created by eHealthMe based on reports of 31 people who take the same drugs from the FDA, and is updated regularly.

What is Ozempic?

Ozempic has active ingredients of semaglutide. It is often used in weight loss. eHealthMe is studying from 29,761 Ozempic users. Check the latest studies of Ozempic.

What is Cefdinir?

Cefdinir has active ingredients of cefdinir. It is often used in sinusitis. eHealthMe is studying from 9,210 Cefdinir users. Check the latest studies of Cefdinir.



On Jul, 17, 2026

31 people who take Ozempic and Cefdinir together, and have interactions are studied.

Ozempic and Cefdinir drug interactions.

What are the common drug interactions of Ozempic and Cefdinir, by gender? *:

female:

  1. Productive cough
  2. Pruritus allergic (severe allergic itching of the skin)
  3. Renal tubular necrosis (death of kidney tubules)
  4. Respiratory failure (inadequate gas exchange by the respiratory system)
  5. Respiratory tract infection
  6. Stridor
  7. Throat tightness
  8. Urinary retention (the inability to completely or partially empty the bladder)
  9. Urinary tract infection
  10. Weight increased

male:

  1. Death
  2. Cataract (clouding of the lens inside the eye)
  3. Wound
  4. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  5. Anxiety
  6. Blood pressure increased
  7. Bone density decreased
  8. Bone pain
  9. Chronic kidney disease
  10. Drug resistance (reduction in effectiveness of a drug)

What are the common drug interactions of Ozempic and Cefdinir, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Asthma
  2. Respiratory disorder (respiratory disease)
  3. Dizziness
  4. Nausea (feeling of having an urge to vomit)
  5. Vomiting
  6. Abdominal pain
  7. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  8. Blood potassium decreased
  9. Cardiac failure congestive
  10. Cellulitis (infection under the skin)

40-49:

  1. Nausea (feeling of having an urge to vomit)
  2. Localised infection (infection at the single location)
  3. Osteomyelitis (infection of bone)
  4. Abscess oral (abscess in the mouth)
  5. Adrenal insufficiency (a condition in which the adrenal glands do not produce adequate amounts of steroids)
  6. C-reactive protein increased
  7. Cardiac disorder
  8. Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
  9. Dyspnoea (difficult or laboured respiration)
  10. Fluid retention (an abnormal accumulation of fluid in the blood)

50-59:

  1. Cataract (clouding of the lens inside the eye)
  2. Conjunctival erosion (removal of conjunctiva)
  3. Death
  4. Herpes zoster

60+:

  1. Autoimmune hepatitis
  2. Death
  3. Congestive cardiomyopathy (weakening of heart muscle)
  4. Diabetic gastroparesis (paralysis of the muscles of the stomach caused by diabetes)
  5. Diabetic neuropathy (neuropathic disorders that are associated with diabetes mellitus)
  6. Eczema (patches of skin become rough and inflamed, with itching and bleeding blisters)
  7. Fatigue (feeling of tiredness)
  8. Gait disturbance
  9. Hyperlipidaemia (presence of excess lipids in the blood)
  10. Inflammation

What are the existing conditions these people have? *

  1. Nausea (feeling of having an urge to vomit): 9 people, 29.03%
  2. Asthma: 6 people, 19.35%
  3. Immunodeficiency Common Variable: 6 people, 19.35%
  4. Fever: 6 people, 19.35%
  5. Diabetes: 4 people, 12.90%
  6. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 12.90%
  7. High Blood Pressure: 4 people, 12.90%
  8. Hypersensitivity: 4 people, 12.90%
  9. Wheezing (a high-pitched whistling sound made while you breath): 4 people, 12.90%
  10. Nausea And Vomiting: 4 people, 12.90%

* Approximation only. Some reports may have incomplete information.

Do you take Ozempic and Cefdinir?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Ozempic and Cefdinir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Ozempic:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Cefdinir:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Ozempic and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Cefdinir and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on semaglutide and cefdinir (the active ingredients of Ozempic and Cefdinir, respectively), and Ozempic and Cefdinir (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: